Aurobindo Pharma Limited
NSE:AUROPHARMA.NS
Overview | Financials
Company Name | Aurobindo Pharma Limited |
Symbol | AUROPHARMA.NS |
Currency | INR |
Price | 1,327.55 |
Market Cap | 771,043,695,100 |
Dividend Yield | 0.39% |
52-week-range | 941.55 - 1,592 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Kambam Nityananda Reddy |
Website | https://www.aurobindo.com |
An error occurred while fetching data.
About Aurobindo Pharma Limited
Aurobindo Pharma Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients, generic pharmaceuticals, and related services in India. The company primarily offers oral solids, injectables, and over-the-counter drugs, as well as active pharmaceutical ingredients and finished dosage forms for cardiovascular, central nervous system, gastroenterology, anti-allergies, anti-diabetics,
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD